Claims
- 1. A b-stage curable composition comprising:
a. a solid component heat curable at a first temperature; b. a liquid component, which is either heat curable at a second temperature or curable upon exposure to radiation in the electromagnetic spectrum; and c. a heat cure catalyst for the solid curable component.
- 2. The composition of claim 1, wherein the solid curable component has a melting point range that is less than the temperature at which the solid curable component cures.
- 3. The composition of claim 1, wherein the solid curable component has a melting point range that is substantially the same as the temperature at which the solid curable component cures.
- 4. The composition of claim 1, further comprising a reactive diluent.
- 5. The composition of claim 1, wherein the composition is substantially free of non-reactive solvent.
- 6. The composition of claim 1, further comprising solvent.
- 7. The composition of claim 1, further comprising a filler.
- 8. The composition of claim 7, wherein the wherein the filler is conductive.
- 9. The composition of claim 7, wherein the filler is thermally conductive.
- 10. The composition of claim 7, wherein the filler is electrically conductive.
- 11. The composition of claim 7, wherein the filler is non-conductive.
- 12. The composition of claim 7, wherein the filler has a particle size of less than about 50 microns.
- 13. The composition of claim 1, further comprising a photoinitiator.
- 14. The composition of claim 13, wherein the photoinitiator is selected from the group consisting of catalysts triggered by radiation in the UV, UV/VIS, VIS, IR, E-beam, X-ray, and microwave ranges of the electromagnetic spectrum.
- 15. The composition of claim 1, wherein heat cure catalyst is selected from the group consisting of free radical catalysts, anionic curatives, cationic curatives, and combinations thereof.
- 16. The composition of claim 15, wherein the free radical catalyst is a member selected from the group consisting of peroxides, azo compounds, and combinations thereof.
- 17. The composition of claim 15, wherein the anionic curative is a member selected from the group consisting of aza compounds, amine compounds, imidazole compounds, and combinations thereof.
- 18. The composition of claim 17, wherein the aza compounds comprise one or more members selected from the group consisting of
- 19. The composition of claim 17, wherein the amine compounds comprise one or more members selected from the group consisting of aliphatic polyamines, aromatic polyamines, alicyclic polyamines, and combinations thereof.
- 20. The composition of claim 17, wherein the amine compounds comprise one or more members selected from the group consisting of diethylenetriamine, triethylenetetraamine, diethylaminopropylamine, benzyl dimethylamine, m-xylenediamine, diaminodiphenylamine, quinoxaline, isophoronediamine, menthenediamine and combinations thereof.
- 21. The composition of claim 17, wherein the imidazole compounds comprise one or more members selected from the group consisting of isoimidazole, imidazole, 2-ethyl-4-methylimidazole, 2,4-dimethylimidazole, butylimidazole, 2-heptadecenyl-4-methylimidazole, 2-methylimidazole, 2-undecenylimidazole, 1-vinyl-2-methylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenylimidazole, 1-benzyl-2-methylimidazole, 1-propyl-2-methylimidazole, 1-cyanoethyl-2-methylimidazole, 1-cyanoethyl-2-ethyl-4-methylimidazole, 1-cyanoethyl-2-undecylimidazole, 1-cyanoethyl-2-phenylimidazole, 1-guanaminoethyl-2-methylimidazole, addition products of an imidazole and methylimidazole, addition products of an imidazole and trimellitic acid, 2-n-heptadecyl-4-methylimidazole, phenylimidazole, benzylimidazole, 2-methyl-4,5-diphenylimidazole, 2,3,5-triphenylimidazole, 2-styrylimidazole, 1-(dodecyl benzyl)-2-methylimidazole, 2-(2-hydroxyl-4-t-butylphenyl)-4,5-diphenylimidazole, 2-(2-methoxyphenyl)-4,5-diphenylimidazole, 2-(3-hydroxyphenyl)-4,5-diphenylimidazole, 2-(p-dimethylaminophenyl)-4,5-diphenylimidazole, 2-(2-hydroxyphenyl)-4,5-diphenylimidazole, di(4,5-diphenyl-2-imidazole)-benzene-1,4,2-naphthyl-4,5-diphenylimidazole, 1-benzyl-2-methylimidazole, 2-p-methoxystyrylimidazole, and combinations thereof.
- 22. The composition of claim 15, wherein the cationic curative is a member selected from the group consisting of organic acids, anhydrides, Lewis acids, and combinations thereof.
- 23. The composition of claim 22, wherein the organic acid is a member selected from the group consisting of phenols, thiophenols, thiols, carboxylic acids, and combinations thereof.
- 24. The composition of claim 1, further comprising a second heat cure catalyst for the liquid curable component.
- 25. The composition of claim 24, wherein cure of the liquid curable component by the second heat cure catalyst occurs at a temperature within the range of about 50° C. to about 150° C. and cure of the solid curable component by the first heat cure catalyst occurs at a temperature within the range of about 100° C. to about 300° C.
- 26. The composition of claim 24, wherein cure of the liquid curable component by the second heat cure catalyst occurs at a temperature less than about 100° C. and cure of the solid curable component by the first heat cure catalyst occurs at a temperature above about 100° C.
- 27. The composition of claim 1, wherein the liquid curable component comprises epoxies, episuldides, maleimides, nadimides, itaconimides, (meth)acrylate, vinyl ethers, vinyl esters, styrene and derivatives thereof, poly(alkenylene)s, allyl amides, norbornenyls, thiolenes, and combinations thereof.
- 28. The composition of claim 1, wherein the solid curable component comprises epoxies, episulfides, maleimides, nadimides, itaconimides, (meth)acrylate, vinyl ethers, vinyl esters, styrene and derivatives thereof, poly(alkenylene)s, allyl amides, norbornenyls, thiolenes, and combinations thereof.
- 29. The composition of claim 1, wherein the liquid curable component is a maleimide-containing compound, an itaconimide-contaning compound or a nadimide-containing compound comprising
- 30. The composition of claim 1, wherein the liquid curable component is a maleimide-containing compound, an itaconimide-contaning compound or a nadimide-containing compound comprising structures I, II and III, wherein
m=1-6, p=0, R2 is independently selected from hydrogen or lower alkyl, and J is a monovalent or polyvalent radical selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, polysiloxane, polysiloxane-polyurethane block copolymer, and combinations of two or more thereof, optionally containing one or more linkers selected from a covalent bond, —O—, —S—, —NR—, —O—C(O)—, —O—C(O)—O—, —O—C(O)—NR—, —NR—C(O)—, —NR—C(O)—O—, —NR—C(O)—NR—, —S—C(O)—, —S—C(O)—O—, —S—C(O)—NR—, —S(O)—, —S(O)2—, —O—S(O)2—, —O—S(O)2—O—, —O—S(O)2—NR—, —O—S(O)—, —O—S(O)—O—, —O—S(O)—NR—, —O—NR—C(O)—, —O—NR—C(O)—O—, —O—NR—C(O)—NR—, —NR—O—C(O)—, —NR—O—C(O)—O—, —NR—O—C(O)—NR—, —O—NR—C(S)—, —O—NR—C(S)—O—, —O—NR—C(S)—NR—, —NR—O—C(S)—, —NR—O—C(S)—O—, —NR—O—C(S)—NR—, —O—C(S)—, —O—C(S)—O—, —O—C(S)—NR—, —NR—C(S)—, —NR—C(S)—O—, —NR—C(S)—NR—, —S—S(O)2—, —S—S(O)2—O—, —S—S(O)2—NR—, —NR—O—S(O)—, —NR—O—S(O)—O—, —NR—O—S(O)—NR—, —NR—O—S(O)2—, —NR—O—S(O)2—O—, —NR—O—S(O)2—NR—, —O—NR—S(O)—, —O—NR—S(O)—O—, —O—NR—S(O)—NR—, —O—NR—S(O)2—O—, —O—NR—S(O)2—NR—, —O—NR—S(O)2—, —O—P(O)R2—, —S—P(O)R2—, —NR—P(O)R2—, wherein each R is independently hydrogen, alkyl or substituted alkyl, and combinations of any two or more thereof.
- 31. The composition of claim 1, wherein the solid curable component is a maleimide-containing compound, an itaconimide-containing compound or a nadimide-containing compound in the solid state at room temperature.
- 32. The composition of claim 31, wherein the maleimide-containing compound, the itaconimide-containing compound or the nadimide-containing compound is a solid and comprises:
- 34. The composition of claim 31, wherein the maleimide-containing compound, the itaconimide-containing compound or the nadimide-containing compound comprises a maleimide functional group, itaconimide functional group or nadimide functional group, respectively, attached to a monovaleht radical or maleimide functional groups, itaconimide functional groups or nadimide functional groups, separated by a polyvalent radical, each of the monovalent radical or the polyvalent radical having sufficient length and branching to render the maleimide-containing compound, the itaconimide-containing compound or the nadimide-containing compound, respectively, a liquid.
- 38. A method of preparing the composition of claim 1, the steps of which comprise
a. providing a solid curable component heat curable at a first temperature, a liquid curable component, which is either heat curable at a second temperature or curable upon exposure to radiation in the electromagnetic spectrum, and a heat cure catalyst for the solid curable component; and b. mixing together the solid curable component, liquid curable component and the heat cure catalyst.
- 39. The method of claim 38, further comprising
c. exposing the composition to conditions favorable to effect cure of the liquid curable component.
- 40. The method of claim 39, further comprising
d. exposing the composition to a temperature condition sufficient to melt the solid curable component.
- 41. The method of claim 40, further comprising
e. exposing the composition to a temperature condition sufficient to cure the melted, solid curable component.
- 42. A method for adhesively attaching a first substrate to a second substrate, said method comprising:
a. applying the composition of claim 1 to one or both of said first substrate or said second substrate; b. exposing the composition-applied substrate to conditions favorable to effect cure of the liquid curable component thereof, thereby forming a b-staged curable film; c. exposing the b-staged curable film of b. to a temperature condition sufficient to melt the solid curable component thereof; d. adjoining said first substrate with said second substrate to form an assembly wherein said first substrate and said second substrate are separated by the composition applied in a.; and e. exposing the curable film of c. to a temperature condition sufficient to cure the melted, solid curable component.
- 43. The method of claim 42, wherein said first substrate is a chip die.
- 44. The method of claim 42, wherein said first substrate and said second substrate are chip die.
- 45. The method of claim 42, wherein said first substrate is a circuit board
- 46. The method of claim 42, wherein said first substrate is a circuit board without solder mask.
- 47. The method of claim 42, wherein said first substrate is a circuit board with solder mask.
- 48. An article of manufacture comprising a semiconductor chip which is provided for attachment to and electrical interconnection with another semiconductor chip or a carrier substrate, the semiconductor chip having a first surface and a second surface, with the first surface having electrical contacts arranged in a predetermined pattern thereon for providing electrical engagement with the another semiconductor chip or the carrier substrate, respectively, and with the second surface having the b stage heat curable composition of claim 1 disposed on a layer or a portion thereof.
RELATED APPLICATION DATA
[0001] This application claims a priority filing date under 35 U.S.C. § 119(e) from U.S. Provisional Application No. 60/428,724, filed Nov. 25, 2002, the disclosure of which is hereby expressly incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60428724 |
Nov 2002 |
US |